Skip to main content
. Author manuscript; available in PMC: 2012 Jul 25.
Published in final edited form as: Arch Intern Med. 2011 Apr 25;171(14):1289–1291. doi: 10.1001/archinternmed.2011.141

Table.

Patient-level and Subgroup-level Costs Attributable to DES

Per Patient*
Per National CAD Subgroup, Annualized
Subgroup Cost, 2002 ($) Cost, 2006 ($) Cost change attributable to DES ($) National subgroup patients, n (millions) Subgroup patients receiving DES in 2006, n (thousands) Subgroup cost increase attributable to DES ($millions)
AMI 35,815 37,345 657 0.36 82.9 236

Non-infarct ACS 26,418 28,278 999 0.27 77.8 269

Non-ACS 10,244 11,667 146 7.30 80.3 1,067

TOTAL CAD 11,952 13,398 198 7.93 241.0 1,572
*

Costs are inflation-adjusted average per-patient costs, including both DES recipients and non-recipients.

2002 costs inflated to 2006 dollars using consumer price index.

Abbreviations: CAD—coronary artery disease; DES—drug-eluting stent; AMI—acute myocardial infarction; ACS—acute coronary syndrome.